Novo Nordisk A/S announced a share repurchase program on August 7, 2024, aiming to repurchase up to DKK 20 billion in shares. As of September 27, 2024, the company has repurchased 12,671,184 B shares at an average price of DKK 880.84, totaling DKK 11.16 billion.